Source:http://linkedlifedata.com/resource/pubmed/id/21509682
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-4-21
|
pubmed:abstractText |
Immunotherapy for patients suffering from multiple myeloma is a lively and emerging field in cancer research. Immunotherapeutic approaches offer unique treatment opportunities for this, to date, mostly incurable disease. Respective basic findings and recent clinical approaches are introduced and discussed. Although several obstacles still need to be overcome, it appears that clinically efficient immunotherapies will become available for multiple myeloma patients in the future.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0080-0015
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
183
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
97-109
|
pubmed:meshHeading |
pubmed-meshheading:21509682-Antigens, Neoplasm,
pubmed-meshheading:21509682-Humans,
pubmed-meshheading:21509682-Immunity, Humoral,
pubmed-meshheading:21509682-Immunotherapy,
pubmed-meshheading:21509682-Immunotherapy, Adoptive,
pubmed-meshheading:21509682-Multiple Myeloma,
pubmed-meshheading:21509682-Stem Cell Transplantation,
pubmed-meshheading:21509682-T-Lymphocytes, Regulatory,
pubmed-meshheading:21509682-Vaccination
|
pubmed:year |
2011
|
pubmed:articleTitle |
Immunology and immunotherapeutic approaches in multiple myeloma.
|
pubmed:publicationType |
Journal Article,
Review
|